Schneyer Mark C. bought ACAD
November 17, 2025 · Form 4 insider transaction
Schneyer Mark C. bought 9,913 shares of ACADIA Pharmaceuticals Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
9,913
Price
N/A
Total value
N/A
InsiderSchneyer Mark C.
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 17, 2025
Filing dateNovember 19, 2025
Shares owned after53,687
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.; Includes 327 shares of the Issuer's common stock acquired by the reporting person on November 14, 2025 pursuant to an employee stock purchase plan.